Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: A meta-analysis of BRF2 as a prognostic biomarker in invasive breast carcinoma

Fig. 2

BRF2 is frequently overexpressed in ductal breast carcinoma. a BRF2 expression frequency by general cancer type. b BRF2 expression frequency by breast cancer sub-type. Red shading denotes BRF2 overexpression. c Scatterplot representing individual patient samples BRF2 expression across the expression value range on x-axis. The Oncomine Power Tools expression data from Affymetrix U133A, U133A 2.0, and U133 Plus 2.0 platforms is quantile normalized whereby the median is calculated across all samples and all genes. The data sets analyzed during the current study are available at https://powertools.oncomine.com/

Back to article page
\